First step: testing new diabetes drug safety in people with kidney issues
NCT ID NCT06929156
Summary
This study aimed to understand how a potential new drug for type 2 diabetes and weight management (BGM0504) is processed by the body in people with impaired kidney function compared to healthy people. It was a small, early-stage (Phase 1) trial that measured drug levels in the blood over time and monitored for side effects. The goal was to gather basic safety and dosing information to guide future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital, Shandong Province)
Jinan, Shandong, 650100, China
Conditions
Explore the condition pages connected to this study.